The Claimants complained that the Defendant wrongly refused to treat as medicinal products the large number of GCPs (glucosamine-containing product) described as ‘food supplements’.
Held: The claim failed.
Supperstone J
[2014] EWHC 1679 (Admin), CO/6789/2013
Bailii
Directive 2001/83/EC
Cited by:
Appeal from – Blue Bio Pharmaceuticals Ltd and Another v Secretary of State for Health and Another CA 17-Jun-2016
The company appealed against rejection of its challenge to the licensing and classification system applied to its products. . .
Lists of cited by and citing cases may be incomplete.
Health Professions, European
Updated: 03 December 2021; Ref: scu.525771